Literature DB >> 7528752

Overcoming obstacles to metastasis--defenses against host defenses: osteopontin (OPN) as a shield against attack by cytotoxic host cells.

D T Denhardt1, A F Chambers.   

Abstract

Osteopontin (OPN) serves both a cell attachment function and a cell signalling function via the alpha v beta 3 integrin. In its cell attachment capacity it can promote attachment of both osteoclasts to bone hydroxyapatite and various other cell types to basement membrane/extracellular matrix. In its cell signalling capacity it initiates a signal transduction cascade that includes changes in the intracellular calcium ion levels and the tyrosine phosphorylation status of several proteins including paxillin. Effects on gene expression include suppression of the induction of nitric oxide synthase by inflammatory mediators. OPN can also reduce cell oxidant levels and inhibit the killing of tumor cells by activated macrophages and endothelial cells. We hypothesize that those cancer cells that produce OPN at elevated levels can suppress the oxidative burst, inhibit NO production, and thus protect themselves from killing by specific host cell types.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7528752     DOI: 10.1002/jcb.240560109

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  21 in total

Review 1.  Bioanalytical techniques for detecting biomarkers of response to human asbestos exposure.

Authors:  Clementina Mesaros; Andrew J Worth; Nathaniel W Snyder; Melpo Christofidou-Solomidou; Anil Vachani; Steven M Albelda; Ian A Blair
Journal:  Bioanalysis       Date:  2015       Impact factor: 2.681

2.  Expression of bone sialoprotein and osteopontin in breast cancer bone metastases.

Authors:  T Ibrahim; I Leong; O Sanchez-Sweatman; R Khokha; J Sodek; H C Tenenbaum; B Ganss; S Cheifetz
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

3.  Differential effects of osteopontin on the cytotoxic activity of macrophages from young and old mice.

Authors:  E E Rollo; D T Denhardt
Journal:  Immunology       Date:  1996-08       Impact factor: 7.397

Review 4.  The importance of the microenvironment in breast cancer progression: recapitulation of mammary tumorigenesis using a unique human mammary epithelial cell model and a three-dimensional culture assay.

Authors:  V M Weaver; A H Fischer; O W Peterson; M J Bissell
Journal:  Biochem Cell Biol       Date:  1996       Impact factor: 3.626

5.  Osteopontin promotes CCL5-mesenchymal stromal cell-mediated breast cancer metastasis.

Authors:  Zhiyong Mi; Syamal D Bhattacharya; Victoria M Kim; Hongtao Guo; Lindsay J Talbot; Paul C Kuo
Journal:  Carcinogenesis       Date:  2011-01-20       Impact factor: 4.944

6.  RNA aptamer blockade of osteopontin inhibits growth and metastasis of MDA-MB231 breast cancer cells.

Authors:  Zhiyong Mi; Hongtao Guo; M Benjamin Russell; Yingmiao Liu; Bruce A Sullenger; Paul C Kuo
Journal:  Mol Ther       Date:  2008-11-04       Impact factor: 11.454

Review 7.  Liver endothelial cells: participation in host response to lymphoma metastasis.

Authors:  V Umansky; M Rocha; V Schirrmacher
Journal:  Cancer Metastasis Rev       Date:  1996-06       Impact factor: 9.264

Review 8.  New insights into tumor-host interactions in lymphoma metastasis.

Authors:  V Umansky; V Schirrmacher; M Rocha
Journal:  J Mol Med (Berl)       Date:  1996-07       Impact factor: 4.599

9.  Osteopontin expression correlates with angiogenesis and survival in malignant astrocytoma.

Authors:  Koviljka Matusan-Ilijas; Senija Behrem; Nives Jonjic; Kamelija Zarkovic; Ksenija Lucin
Journal:  Pathol Oncol Res       Date:  2008-05-21       Impact factor: 3.201

10.  Identification of osteopontin-dependent signaling pathways in a mouse model of human breast cancer.

Authors:  Zhiyong Mi; Hongtao Guo; Paul C Kuo
Journal:  BMC Res Notes       Date:  2009-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.